Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you
Health Care

/

Biotech & Pharma

/

Biotech

Biotech Sub-Industry Dividends

Biotechnology companies utilize living organisms and molecular biology to produce healthcare products and therapeutics. Biotech processes are used in the fields of medicine, pharmaceuticals, genomics, food production and the production of biofuels. The securities listed in this page are organized into two tables. The stock table includes relevant common stocks, ADRs and preferred shares, and the funds table includes relevant exchange-traded funds (ETFs) and institutional share class mutual funds. All securities have an active dividend policy and are either exchange-listed or domiciled in the United States. Dividend.com Premium members have access to premium data within each table. Premium data includes stock ratings (scored out of 5) for overall dividend quality, yield attractiveness, dividend reliability, earnings growth, valuation, and price momentum in addition to payout estimates for future dividends. Premium data is blocked for public users. The stock table is sorted in a descending order by market capitalization and the fund table is sorted in a descending order by net assets. About this page +

Biotechnology companies utilize living organisms and molecular biology to produce healthcare products and therapeutics. Biotech processes are used in the fields of medicine, pharmaceuticals, genomics, ... food production and the production of biofuels. The securities listed in this page are organized into two tables. The stock table includes relevant common stocks, ADRs and preferred shares, and the funds table includes relevant exchange-traded funds (ETFs) and institutional share class mutual funds. All securities have an active dividend policy and are either exchange-listed or domiciled in the United States. Dividend.com Premium members have access to premium data within each table. Premium data includes stock ratings (scored out of 5) for overall dividend quality, yield attractiveness, dividend reliability, earnings growth, valuation, and price momentum in addition to payout estimates for future dividends. Premium data is blocked for public users. The stock table is sorted in a descending order by market capitalization and the fund table is sorted in a descending order by net assets. View more View less

Biotech Sub-Industry Dividend ETFs and Funds Results

Filter by Top Picks*

Filter by Security Type

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings & Recommendations*

$136.49

+0.25%

$9.00 B

0.15%

$0.21

blocked
blocked
blocked

12.12%

0.46%

$117.63

+0.50%

$5.24 B

0.00%

$0.00

blocked
blocked
blocked

22.02%

0.35%

$48.44

-0.98%

$69.34 M

16.66%

$8.15

blocked
blocked
blocked

307.04%

1.07%

$25.94

+0.34%

$22.90 M

2.51%

$0.65

blocked
blocked
blocked

-16.59%

0.35%

$30.13

-0.53%

$12.29 M

4.08%

$1.24

blocked
blocked
blocked

128.88%

1.31%

Biotech Sub-Industry Dividend Stocks Results

Filter by Top Picks*

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Dividend.com Ratings & Recommendations*

AMGEN Inc.

AMGN | Stock | Common

$224.89

-1.00%

$133.05 B

2.55%

$5.80

blocked
blocked
blocked
Gilead Sciences, Inc.

GILD | Stock | Common

$59.96

-1.37%

$76.21 B

4.15%

$2.52

blocked
blocked
blocked
Livongo Health Inc

LVGO | Stock |

$136.67

-1.61%

$14.11 B

0.00%

$0.00

blocked
blocked
blocked
Grifols SA - ADR - Level III

GRFS | Stock | Common

$18.04

-2.54%

$12.73 B

2.09%

$0.39

blocked
blocked
blocked
H. Lundbeck AS - ADR

HLUYY | Stock |

$29.61

-4.33%

$6.16 B

5.83%

$1.80

blocked
blocked
blocked
Merrimack Pharmaceuticals Inc

MACK | Stock | Common

$3.86

+0.26%

$51.51 M

0.00%

$0.00

blocked
blocked
blocked

$0.15

-6.25%

$11.84 M

0.00%

$0.00

blocked
blocked
blocked

Get the latest dividend news in your inbox each week.

Receive the latest news, trending tickers, top stocks increasing dividend this week and more.